Global Synovial Sarcoma Treatment Market Insights and Forecast to 2031

Report ID: 1564029 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Synovial Sarcoma Treatment Product Introduction
    1.2 Market by Type
        1.2.1 Global Synovial Sarcoma Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 ACXT-3102
        1.2.3 AL-3818
        1.2.4 Axitinib
        1.2.5 CMB-305
        1.2.6 CUE-102
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Synovial Sarcoma Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Synovial Sarcoma Treatment Sales Estimates and Forecasts 2017-2028
    2.2 Global Synovial Sarcoma Treatment Revenue Estimates and Forecasts 2017-2028
    2.3 Global Synovial Sarcoma Treatment Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Synovial Sarcoma Treatment Sales by Region
        2.4.1 Global Synovial Sarcoma Treatment Sales by Region (2017-2022)
        2.4.2 Global Sales Synovial Sarcoma Treatment by Region (2023-2028)
    2.5 Global Synovial Sarcoma Treatment Revenue by Region
        2.5.1 Global Synovial Sarcoma Treatment Revenue by Region (2017-2022)
        2.5.2 Global Synovial Sarcoma Treatment Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Synovial Sarcoma Treatment Sales by Manufacturers
        3.1.1 Global Top Synovial Sarcoma Treatment Manufacturers by Sales (2017-2022)
        3.1.2 Global Synovial Sarcoma Treatment Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Synovial Sarcoma Treatment in 2021
    3.2 Global Synovial Sarcoma Treatment Revenue by Manufacturers
        3.2.1 Global Synovial Sarcoma Treatment Revenue by Manufacturers (2017-2022)
        3.2.2 Global Synovial Sarcoma Treatment Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Synovial Sarcoma Treatment Revenue in 2021
    3.3 Global Synovial Sarcoma Treatment Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Synovial Sarcoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Synovial Sarcoma Treatment Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Synovial Sarcoma Treatment Sales by Type
        4.1.1 Global Synovial Sarcoma Treatment Historical Sales by Type (2017-2022)
        4.1.2 Global Synovial Sarcoma Treatment Forecasted Sales by Type (2023-2028)
        4.1.3 Global Synovial Sarcoma Treatment Sales Market Share by Type (2017-2028)
    4.2 Global Synovial Sarcoma Treatment Revenue by Type
        4.2.1 Global Synovial Sarcoma Treatment Historical Revenue by Type (2017-2022)
        4.2.2 Global Synovial Sarcoma Treatment Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Synovial Sarcoma Treatment Revenue Market Share by Type (2017-2028)
    4.3 Global Synovial Sarcoma Treatment Price by Type
        4.3.1 Global Synovial Sarcoma Treatment Price by Type (2017-2022)
        4.3.2 Global Synovial Sarcoma Treatment Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Synovial Sarcoma Treatment Sales by Application
        5.1.1 Global Synovial Sarcoma Treatment Historical Sales by Application (2017-2022)
        5.1.2 Global Synovial Sarcoma Treatment Forecasted Sales by Application (2023-2028)
        5.1.3 Global Synovial Sarcoma Treatment Sales Market Share by Application (2017-2028)
    5.2 Global Synovial Sarcoma Treatment Revenue by Application
        5.2.1 Global Synovial Sarcoma Treatment Historical Revenue by Application (2017-2022)
        5.2.2 Global Synovial Sarcoma Treatment Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Synovial Sarcoma Treatment Revenue Market Share by Application (2017-2028)
    5.3 Global Synovial Sarcoma Treatment Price by Application
        5.3.1 Global Synovial Sarcoma Treatment Price by Application (2017-2022)
        5.3.2 Global Synovial Sarcoma Treatment Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Synovial Sarcoma Treatment Market Size by Type
        6.1.1 North America Synovial Sarcoma Treatment Sales by Type (2017-2028)
        6.1.2 North America Synovial Sarcoma Treatment Revenue by Type (2017-2028)
    6.2 North America Synovial Sarcoma Treatment Market Size by Application
        6.2.1 North America Synovial Sarcoma Treatment Sales by Application (2017-2028)
        6.2.2 North America Synovial Sarcoma Treatment Revenue by Application (2017-2028)
    6.3 North America Synovial Sarcoma Treatment Market Size by Country
        6.3.1 North America Synovial Sarcoma Treatment Sales by Country (2017-2028)
        6.3.2 North America Synovial Sarcoma Treatment Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Synovial Sarcoma Treatment Market Size by Type
        7.1.1 Europe Synovial Sarcoma Treatment Sales by Type (2017-2028)
        7.1.2 Europe Synovial Sarcoma Treatment Revenue by Type (2017-2028)
    7.2 Europe Synovial Sarcoma Treatment Market Size by Application
        7.2.1 Europe Synovial Sarcoma Treatment Sales by Application (2017-2028)
        7.2.2 Europe Synovial Sarcoma Treatment Revenue by Application (2017-2028)
    7.3 Europe Synovial Sarcoma Treatment Market Size by Country
        7.3.1 Europe Synovial Sarcoma Treatment Sales by Country (2017-2028)
        7.3.2 Europe Synovial Sarcoma Treatment Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Synovial Sarcoma Treatment Market Size by Type
        8.1.1 Asia Pacific Synovial Sarcoma Treatment Sales by Type (2017-2028)
        8.1.2 Asia Pacific Synovial Sarcoma Treatment Revenue by Type (2017-2028)
    8.2 Asia Pacific Synovial Sarcoma Treatment Market Size by Application
        8.2.1 Asia Pacific Synovial Sarcoma Treatment Sales by Application (2017-2028)
        8.2.2 Asia Pacific Synovial Sarcoma Treatment Revenue by Application (2017-2028)
    8.3 Asia Pacific Synovial Sarcoma Treatment Market Size by Region
        8.3.1 Asia Pacific Synovial Sarcoma Treatment Sales by Region (2017-2028)
        8.3.2 Asia Pacific Synovial Sarcoma Treatment Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Synovial Sarcoma Treatment Market Size by Type
        9.1.1 Latin America Synovial Sarcoma Treatment Sales by Type (2017-2028)
        9.1.2 Latin America Synovial Sarcoma Treatment Revenue by Type (2017-2028)
    9.2 Latin America Synovial Sarcoma Treatment Market Size by Application
        9.2.1 Latin America Synovial Sarcoma Treatment Sales by Application (2017-2028)
        9.2.2 Latin America Synovial Sarcoma Treatment Revenue by Application (2017-2028)
    9.3 Latin America Synovial Sarcoma Treatment Market Size by Country
        9.3.1 Latin America Synovial Sarcoma Treatment Sales by Country (2017-2028)
        9.3.2 Latin America Synovial Sarcoma Treatment Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Synovial Sarcoma Treatment Market Size by Type
        10.1.1 Middle East and Africa Synovial Sarcoma Treatment Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Synovial Sarcoma Treatment Revenue by Type (2017-2028)
    10.2 Middle East and Africa Synovial Sarcoma Treatment Market Size by Application
        10.2.1 Middle East and Africa Synovial Sarcoma Treatment Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Synovial Sarcoma Treatment Revenue by Application (2017-2028)
    10.3 Middle East and Africa Synovial Sarcoma Treatment Market Size by Country
        10.3.1 Middle East and Africa Synovial Sarcoma Treatment Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Synovial Sarcoma Treatment Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Adaptimmune Therapeutics Plc
        11.1.1 Adaptimmune Therapeutics Plc Corporation Information
        11.1.2 Adaptimmune Therapeutics Plc Overview
        11.1.3 Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Adaptimmune Therapeutics Plc Recent Developments
    11.2 Advenchen Laboratories LLC
        11.2.1 Advenchen Laboratories LLC Corporation Information
        11.2.2 Advenchen Laboratories LLC Overview
        11.2.3 Advenchen Laboratories LLC Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Advenchen Laboratories LLC Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Advenchen Laboratories LLC Recent Developments
    11.3 EpiZyme Inc
        11.3.1 EpiZyme Inc Corporation Information
        11.3.2 EpiZyme Inc Overview
        11.3.3 EpiZyme Inc Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 EpiZyme Inc Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 EpiZyme Inc Recent Developments
    11.4 Immune Design Corp
        11.4.1 Immune Design Corp Corporation Information
        11.4.2 Immune Design Corp Overview
        11.4.3 Immune Design Corp Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Immune Design Corp Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Immune Design Corp Recent Developments
    11.5 Immunocore Ltd
        11.5.1 Immunocore Ltd Corporation Information
        11.5.2 Immunocore Ltd Overview
        11.5.3 Immunocore Ltd Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Immunocore Ltd Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Immunocore Ltd Recent Developments
    11.6 Johnson & Johnson
        11.6.1 Johnson & Johnson Corporation Information
        11.6.2 Johnson & Johnson Overview
        11.6.3 Johnson & Johnson Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Johnson & Johnson Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Johnson & Johnson Recent Developments
    11.7 Karyopharm Therapeutics Inc
        11.7.1 Karyopharm Therapeutics Inc Corporation Information
        11.7.2 Karyopharm Therapeutics Inc Overview
        11.7.3 Karyopharm Therapeutics Inc Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Karyopharm Therapeutics Inc Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Karyopharm Therapeutics Inc Recent Developments
    11.8 Merck & Co Inc
        11.8.1 Merck & Co Inc Corporation Information
        11.8.2 Merck & Co Inc Overview
        11.8.3 Merck & Co Inc Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Merck & Co Inc Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Merck & Co Inc Recent Developments
    11.9 Millennium Pharmaceuticals Inc
        11.9.1 Millennium Pharmaceuticals Inc Corporation Information
        11.9.2 Millennium Pharmaceuticals Inc Overview
        11.9.3 Millennium Pharmaceuticals Inc Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Millennium Pharmaceuticals Inc Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Millennium Pharmaceuticals Inc Recent Developments
    11.10 Novartis AG
        11.10.1 Novartis AG Corporation Information
        11.10.2 Novartis AG Overview
        11.10.3 Novartis AG Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Novartis AG Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Novartis AG Recent Developments
    11.11 Pfizer Inc
        11.11.1 Pfizer Inc Corporation Information
        11.11.2 Pfizer Inc Overview
        11.11.3 Pfizer Inc Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Pfizer Inc Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Pfizer Inc Recent Developments
    11.12 Takara Bio Inc
        11.12.1 Takara Bio Inc Corporation Information
        11.12.2 Takara Bio Inc Overview
        11.12.3 Takara Bio Inc Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Takara Bio Inc Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Takara Bio Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Synovial Sarcoma Treatment Industry Chain Analysis
    12.2 Synovial Sarcoma Treatment Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Synovial Sarcoma Treatment Production Mode & Process
    12.4 Synovial Sarcoma Treatment Sales and Marketing
        12.4.1 Synovial Sarcoma Treatment Sales Channels
        12.4.2 Synovial Sarcoma Treatment Distributors
    12.5 Synovial Sarcoma Treatment Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Synovial Sarcoma Treatment Industry Trends
    13.2 Synovial Sarcoma Treatment Market Drivers
    13.3 Synovial Sarcoma Treatment Market Challenges
    13.4 Synovial Sarcoma Treatment Market Restraints
14 Key Findings in The Global Synovial Sarcoma Treatment Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Synovial Sarcoma Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of ACXT-3102
    Table 3. Major Manufacturers of AL-3818
    Table 4. Major Manufacturers of Axitinib
    Table 5. Major Manufacturers of CMB-305
    Table 6. Major Manufacturers of CUE-102
    Table 7. Major Manufacturers of Others
    Table 8. Global Synovial Sarcoma Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Synovial Sarcoma Treatment Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 10. Global Synovial Sarcoma Treatment Sales by Region (2017-2022) & (K Pcs)
    Table 11. Global Synovial Sarcoma Treatment Sales Market Share by Region (2017-2022)
    Table 12. Global Synovial Sarcoma Treatment Sales by Region (2023-2028) & (K Pcs)
    Table 13. Global Synovial Sarcoma Treatment Sales Market Share by Region (2023-2028)
    Table 14. Global Synovial Sarcoma Treatment Revenue by Region (2017-2022) & (US$ Million)
    Table 15. Global Synovial Sarcoma Treatment Revenue Market Share by Region (2017-2022)
    Table 16. Global Synovial Sarcoma Treatment Revenue by Region (2023-2028) & (US$ Million)
    Table 17. Global Synovial Sarcoma Treatment Revenue Market Share by Region (2023-2028)
    Table 18. Global Synovial Sarcoma Treatment Sales by Manufacturers (2017-2022) & (K Pcs)
    Table 19. Global Synovial Sarcoma Treatment Sales Share by Manufacturers (2017-2022)
    Table 20. Global Synovial Sarcoma Treatment Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 21. Global Synovial Sarcoma Treatment Revenue Share by Manufacturers (2017-2022)
    Table 22. Synovial Sarcoma Treatment Price by Manufacturers (2017-2022) &(USD/Pcs)
    Table 23. Global Synovial Sarcoma Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global Synovial Sarcoma Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synovial Sarcoma Treatment as of 2021)
    Table 25. Synovial Sarcoma Treatment Manufacturing Base Distribution and Headquarters
    Table 26. Manufacturers Synovial Sarcoma Treatment Product Offered
    Table 27. Date of Manufacturers Enter into Synovial Sarcoma Treatment Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Synovial Sarcoma Treatment Sales by Type (2017-2022) & (K Pcs)
    Table 30. Global Synovial Sarcoma Treatment Sales by Type (2023-2028) & (K Pcs)
    Table 31. Global Synovial Sarcoma Treatment Sales Share by Type (2017-2022)
    Table 32. Global Synovial Sarcoma Treatment Sales Share by Type (2023-2028)
    Table 33. Global Synovial Sarcoma Treatment Revenue by Type (2017-2022) & (US$ Million)
    Table 34. Global Synovial Sarcoma Treatment Revenue by Type (2023-2028) & (US$ Million)
    Table 35. Global Synovial Sarcoma Treatment Revenue Share by Type (2017-2022)
    Table 36. Global Synovial Sarcoma Treatment Revenue Share by Type (2023-2028)
    Table 37. Synovial Sarcoma Treatment Price by Type (2017-2022) & (USD/Pcs)
    Table 38. Global Synovial Sarcoma Treatment Price Forecast by Type (2023-2028) & (USD/Pcs)
    Table 39. Global Synovial Sarcoma Treatment Sales by Application (2017-2022) & (K Pcs)
    Table 40. Global Synovial Sarcoma Treatment Sales by Application (2023-2028) & (K Pcs)
    Table 41. Global Synovial Sarcoma Treatment Sales Share by Application (2017-2022)
    Table 42. Global Synovial Sarcoma Treatment Sales Share by Application (2023-2028)
    Table 43. Global Synovial Sarcoma Treatment Revenue by Application (2017-2022) & (US$ Million)
    Table 44. Global Synovial Sarcoma Treatment Revenue by Application (2023-2028) & (US$ Million)
    Table 45. Global Synovial Sarcoma Treatment Revenue Share by Application (2017-2022)
    Table 46. Global Synovial Sarcoma Treatment Revenue Share by Application (2023-2028)
    Table 47. Synovial Sarcoma Treatment Price by Application (2017-2022) & (USD/Pcs)
    Table 48. Global Synovial Sarcoma Treatment Price Forecast by Application (2023-2028) & (USD/Pcs)
    Table 49. North America Synovial Sarcoma Treatment Sales by Type (2017-2022) & (K Pcs)
    Table 50. North America Synovial Sarcoma Treatment Sales by Type (2023-2028) & (K Pcs)
    Table 51. North America Synovial Sarcoma Treatment Revenue by Type (2017-2022) & (US$ Million)
    Table 52. North America Synovial Sarcoma Treatment Revenue by Type (2023-2028) & (US$ Million)
    Table 53. North America Synovial Sarcoma Treatment Sales by Application (2017-2022) & (K Pcs)
    Table 54. North America Synovial Sarcoma Treatment Sales by Application (2023-2028) & (K Pcs)
    Table 55. North America Synovial Sarcoma Treatment Revenue by Application (2017-2022) & (US$ Million)
    Table 56. North America Synovial Sarcoma Treatment Revenue by Application (2023-2028) & (US$ Million)
    Table 57. North America Synovial Sarcoma Treatment Sales by Country (2017-2022) & (K Pcs)
    Table 58. North America Synovial Sarcoma Treatment Sales by Country (2023-2028) & (K Pcs)
    Table 59. North America Synovial Sarcoma Treatment Revenue by Country (2017-2022) & (US$ Million)
    Table 60. North America Synovial Sarcoma Treatment Revenue by Country (2023-2028) & (US$ Million)
    Table 61. Europe Synovial Sarcoma Treatment Sales by Type (2017-2022) & (K Pcs)
    Table 62. Europe Synovial Sarcoma Treatment Sales by Type (2023-2028) & (K Pcs)
    Table 63. Europe Synovial Sarcoma Treatment Revenue by Type (2017-2022) & (US$ Million)
    Table 64. Europe Synovial Sarcoma Treatment Revenue by Type (2023-2028) & (US$ Million)
    Table 65. Europe Synovial Sarcoma Treatment Sales by Application (2017-2022) & (K Pcs)
    Table 66. Europe Synovial Sarcoma Treatment Sales by Application (2023-2028) & (K Pcs)
    Table 67. Europe Synovial Sarcoma Treatment Revenue by Application (2017-2022) & (US$ Million)
    Table 68. Europe Synovial Sarcoma Treatment Revenue by Application (2023-2028) & (US$ Million)
    Table 69. Europe Synovial Sarcoma Treatment Sales by Country (2017-2022) & (K Pcs)
    Table 70. Europe Synovial Sarcoma Treatment Sales by Country (2023-2028) & (K Pcs)
    Table 71. Europe Synovial Sarcoma Treatment Revenue by Country (2017-2022) & (US$ Million)
    Table 72. Europe Synovial Sarcoma Treatment Revenue by Country (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Synovial Sarcoma Treatment Sales by Type (2017-2022) & (K Pcs)
    Table 74. Asia Pacific Synovial Sarcoma Treatment Sales by Type (2023-2028) & (K Pcs)
    Table 75. Asia Pacific Synovial Sarcoma Treatment Revenue by Type (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Synovial Sarcoma Treatment Revenue by Type (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Synovial Sarcoma Treatment Sales by Application (2017-2022) & (K Pcs)
    Table 78. Asia Pacific Synovial Sarcoma Treatment Sales by Application (2023-2028) & (K Pcs)
    Table 79. Asia Pacific Synovial Sarcoma Treatment Revenue by Application (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Synovial Sarcoma Treatment Revenue by Application (2023-2028) & (US$ Million)
    Table 81. Asia Pacific Synovial Sarcoma Treatment Sales by Region (2017-2022) & (K Pcs)
    Table 82. Asia Pacific Synovial Sarcoma Treatment Sales by Region (2023-2028) & (K Pcs)
    Table 83. Asia Pacific Synovial Sarcoma Treatment Revenue by Region (2017-2022) & (US$ Million)
    Table 84. Asia Pacific Synovial Sarcoma Treatment Revenue by Region (2023-2028) & (US$ Million)
    Table 85. Latin America Synovial Sarcoma Treatment Sales by Type (2017-2022) & (K Pcs)
    Table 86. Latin America Synovial Sarcoma Treatment Sales by Type (2023-2028) & (K Pcs)
    Table 87. Latin America Synovial Sarcoma Treatment Revenue by Type (2017-2022) & (US$ Million)
    Table 88. Latin America Synovial Sarcoma Treatment Revenue by Type (2023-2028) & (US$ Million)
    Table 89. Latin America Synovial Sarcoma Treatment Sales by Application (2017-2022) & (K Pcs)
    Table 90. Latin America Synovial Sarcoma Treatment Sales by Application (2023-2028) & (K Pcs)
    Table 91. Latin America Synovial Sarcoma Treatment Revenue by Application (2017-2022) & (US$ Million)
    Table 92. Latin America Synovial Sarcoma Treatment Revenue by Application (2023-2028) & (US$ Million)
    Table 93. Latin America Synovial Sarcoma Treatment Sales by Country (2017-2022) & (K Pcs)
    Table 94. Latin America Synovial Sarcoma Treatment Sales by Country (2023-2028) & (K Pcs)
    Table 95. Latin America Synovial Sarcoma Treatment Revenue by Country (2017-2022) & (US$ Million)
    Table 96. Latin America Synovial Sarcoma Treatment Revenue by Country (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Synovial Sarcoma Treatment Sales by Type (2017-2022) & (K Pcs)
    Table 98. Middle East and Africa Synovial Sarcoma Treatment Sales by Type (2023-2028) & (K Pcs)
    Table 99. Middle East and Africa Synovial Sarcoma Treatment Revenue by Type (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Synovial Sarcoma Treatment Revenue by Type (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Synovial Sarcoma Treatment Sales by Application (2017-2022) & (K Pcs)
    Table 102. Middle East and Africa Synovial Sarcoma Treatment Sales by Application (2023-2028) & (K Pcs)
    Table 103. Middle East and Africa Synovial Sarcoma Treatment Revenue by Application (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Synovial Sarcoma Treatment Revenue by Application (2023-2028) & (US$ Million)
    Table 105. Middle East and Africa Synovial Sarcoma Treatment Sales by Country (2017-2022) & (K Pcs)
    Table 106. Middle East and Africa Synovial Sarcoma Treatment Sales by Country (2023-2028) & (K Pcs)
    Table 107. Middle East and Africa Synovial Sarcoma Treatment Revenue by Country (2017-2022) & (US$ Million)
    Table 108. Middle East and Africa Synovial Sarcoma Treatment Revenue by Country (2023-2028) & (US$ Million)
    Table 109. Adaptimmune Therapeutics Plc Corporation Information
    Table 110. Adaptimmune Therapeutics Plc Description and Major Businesses
    Table 111. Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 112. Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 113. Adaptimmune Therapeutics Plc Recent Developments
    Table 114. Advenchen Laboratories LLC Corporation Information
    Table 115. Advenchen Laboratories LLC Description and Major Businesses
    Table 116. Advenchen Laboratories LLC Synovial Sarcoma Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 117. Advenchen Laboratories LLC Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. Advenchen Laboratories LLC Recent Developments
    Table 119. EpiZyme Inc Corporation Information
    Table 120. EpiZyme Inc Description and Major Businesses
    Table 121. EpiZyme Inc Synovial Sarcoma Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 122. EpiZyme Inc Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. EpiZyme Inc Recent Developments
    Table 124. Immune Design Corp Corporation Information
    Table 125. Immune Design Corp Description and Major Businesses
    Table 126. Immune Design Corp Synovial Sarcoma Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 127. Immune Design Corp Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. Immune Design Corp Recent Developments
    Table 129. Immunocore Ltd Corporation Information
    Table 130. Immunocore Ltd Description and Major Businesses
    Table 131. Immunocore Ltd Synovial Sarcoma Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 132. Immunocore Ltd Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 133. Immunocore Ltd Recent Developments
    Table 134. Johnson & Johnson Corporation Information
    Table 135. Johnson & Johnson Description and Major Businesses
    Table 136. Johnson & Johnson Synovial Sarcoma Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 137. Johnson & Johnson Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 138. Johnson & Johnson Recent Developments
    Table 139. Karyopharm Therapeutics Inc Corporation Information
    Table 140. Karyopharm Therapeutics Inc Description and Major Businesses
    Table 141. Karyopharm Therapeutics Inc Synovial Sarcoma Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 142. Karyopharm Therapeutics Inc Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 143. Karyopharm Therapeutics Inc Recent Developments
    Table 144. Merck & Co Inc Corporation Information
    Table 145. Merck & Co Inc Description and Major Businesses
    Table 146. Merck & Co Inc Synovial Sarcoma Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 147. Merck & Co Inc Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 148. Merck & Co Inc Recent Developments
    Table 149. Millennium Pharmaceuticals Inc Corporation Information
    Table 150. Millennium Pharmaceuticals Inc Description and Major Businesses
    Table 151. Millennium Pharmaceuticals Inc Synovial Sarcoma Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 152. Millennium Pharmaceuticals Inc Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 153. Millennium Pharmaceuticals Inc Recent Developments
    Table 154. Novartis AG Corporation Information
    Table 155. Novartis AG Description and Major Businesses
    Table 156. Novartis AG Synovial Sarcoma Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 157. Novartis AG Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 158. Novartis AG Recent Developments
    Table 159. Pfizer Inc Corporation Information
    Table 160. Pfizer Inc Description and Major Businesses
    Table 161. Pfizer Inc Synovial Sarcoma Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 162. Pfizer Inc Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 163. Pfizer Inc Recent Developments
    Table 164. Takara Bio Inc Corporation Information
    Table 165. Takara Bio Inc Description and Major Businesses
    Table 166. Takara Bio Inc Synovial Sarcoma Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 167. Takara Bio Inc Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 168. Takara Bio Inc Recent Developments
    Table 169. Key Raw Materials Lists
    Table 170. Raw Materials Key Suppliers Lists
    Table 171. Synovial Sarcoma Treatment Distributors List
    Table 172. Synovial Sarcoma Treatment Customers List
    Table 173. Synovial Sarcoma Treatment Market Trends
    Table 174. Synovial Sarcoma Treatment Market Drivers
    Table 175. Synovial Sarcoma Treatment Market Challenges
    Table 176. Synovial Sarcoma Treatment Market Restraints
    Table 177. Research Programs/Design for This Report
    Table 178. Key Data Information from Secondary Sources
    Table 179. Key Data Information from Primary Sources
List of Figures
    Figure 1. Synovial Sarcoma Treatment Product Picture
    Figure 3. Global Synovial Sarcoma Treatment Market Share by Type in 2021 & 2028
    Figure 3. ACXT-3102 Product Picture
    Figure 4. AL-3818 Product Picture
    Figure 5. Axitinib Product Picture
    Figure 6. CMB-305 Product Picture
    Figure 7. CUE-102 Product Picture
    Figure 8. Others Product Picture
    Figure 9. Global Synovial Sarcoma Treatment Market Share by Application in 2021 & 2028
    Figure 10. Hospital
    Figure 11. Clinic
    Figure 12. Others
    Figure 13. Synovial Sarcoma Treatment Report Years Considered
    Figure 14. Global Synovial Sarcoma Treatment Sales 2017-2028 (K Pcs)
    Figure 15. Global Synovial Sarcoma Treatment Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Synovial Sarcoma Treatment Revenue 2017-2028 (US$ Million)
    Figure 17. Global Synovial Sarcoma Treatment Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 18. Global Synovial Sarcoma Treatment Sales Market Share by Region (2017-2022)
    Figure 19. Global Synovial Sarcoma Treatment Sales Market Share by Region (2023-2028)
    Figure 20. North America Synovial Sarcoma Treatment Sales YoY (2017-2028) & (K Pcs)
    Figure 21. North America Synovial Sarcoma Treatment Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Synovial Sarcoma Treatment Sales YoY (2017-2028) & (K Pcs)
    Figure 23. Europe Synovial Sarcoma Treatment Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Asia-Pacific Synovial Sarcoma Treatment Sales YoY (2017-2028) & (K Pcs)
    Figure 25. Asia-Pacific Synovial Sarcoma Treatment Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Latin America Synovial Sarcoma Treatment Sales YoY (2017-2028) & (K Pcs)
    Figure 27. Latin America Synovial Sarcoma Treatment Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Middle East & Africa Synovial Sarcoma Treatment Sales YoY (2017-2028) & (K Pcs)
    Figure 29. Middle East & Africa Synovial Sarcoma Treatment Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. The Synovial Sarcoma Treatment Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 31. The Top 5 and 10 Largest Manufacturers of Synovial Sarcoma Treatment in the World: Market Share by Synovial Sarcoma Treatment Revenue in 2021
    Figure 32. Global Synovial Sarcoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 33. Global Synovial Sarcoma Treatment Sales Market Share by Type (2017-2028)
    Figure 34. Global Synovial Sarcoma Treatment Revenue Market Share by Type (2017-2028)
    Figure 35. Global Synovial Sarcoma Treatment Sales Market Share by Application (2017-2028)
    Figure 36. Global Synovial Sarcoma Treatment Revenue Market Share by Application (2017-2028)
    Figure 37. North America Synovial Sarcoma Treatment Sales Market Share by Type (2017-2028)
    Figure 38. North America Synovial Sarcoma Treatment Revenue Market Share by Type (2017-2028)
    Figure 39. North America Synovial Sarcoma Treatment Sales Market Share by Application (2017-2028)
    Figure 40. North America Synovial Sarcoma Treatment Revenue Market Share by Application (2017-2028)
    Figure 41. North America Synovial Sarcoma Treatment Sales Share by Country (2017-2028)
    Figure 42. North America Synovial Sarcoma Treatment Revenue Share by Country (2017-2028)
    Figure 43. U.S. Synovial Sarcoma Treatment Revenue (2017-2028) & (US$ Million)
    Figure 44. Canada Synovial Sarcoma Treatment Revenue (2017-2028) & (US$ Million)
    Figure 45. Europe Synovial Sarcoma Treatment Sales Market Share by Type (2017-2028)
    Figure 46. Europe Synovial Sarcoma Treatment Revenue Market Share by Type (2017-2028)
    Figure 47. Europe Synovial Sarcoma Treatment Sales Market Share by Application (2017-2028)
    Figure 48. Europe Synovial Sarcoma Treatment Revenue Market Share by Application (2017-2028)
    Figure 49. Europe Synovial Sarcoma Treatment Sales Share by Country (2017-2028)
    Figure 50. Europe Synovial Sarcoma Treatment Revenue Share by Country (2017-2028)
    Figure 51. Germany Synovial Sarcoma Treatment Revenue (2017-2028) & (US$ Million)
    Figure 52. France Synovial Sarcoma Treatment Revenue (2017-2028) & (US$ Million)
    Figure 53. U.K. Synovial Sarcoma Treatment Revenue (2017-2028) & (US$ Million)
    Figure 54. Italy Synovial Sarcoma Treatment Revenue (2017-2028) & (US$ Million)
    Figure 55. Russia Synovial Sarcoma Treatment Revenue (2017-2028) & (US$ Million)
    Figure 56. Asia Pacific Synovial Sarcoma Treatment Sales Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Synovial Sarcoma Treatment Revenue Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Synovial Sarcoma Treatment Sales Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Synovial Sarcoma Treatment Revenue Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Synovial Sarcoma Treatment Sales Share by Region (2017-2028)
    Figure 61. Asia Pacific Synovial Sarcoma Treatment Revenue Share by Region (2017-2028)
    Figure 62. China Synovial Sarcoma Treatment Revenue (2017-2028) & (US$ Million)
    Figure 63. Japan Synovial Sarcoma Treatment Revenue (2017-2028) & (US$ Million)
    Figure 64. South Korea Synovial Sarcoma Treatment Revenue (2017-2028) & (US$ Million)
    Figure 65. India Synovial Sarcoma Treatment Revenue (2017-2028) & (US$ Million)
    Figure 66. Australia Synovial Sarcoma Treatment Revenue (2017-2028) & (US$ Million)
    Figure 67. Taiwan Synovial Sarcoma Treatment Revenue (2017-2028) & (US$ Million)
    Figure 68. Indonesia Synovial Sarcoma Treatment Revenue (2017-2028) & (US$ Million)
    Figure 69. Thailand Synovial Sarcoma Treatment Revenue (2017-2028) & (US$ Million)
    Figure 70. Malaysia Synovial Sarcoma Treatment Revenue (2017-2028) & (US$ Million)
    Figure 71. Philippines Synovial Sarcoma Treatment Revenue (2017-2028) & (US$ Million)
    Figure 72. Latin America Synovial Sarcoma Treatment Sales Market Share by Type (2017-2028)
    Figure 73. Latin America Synovial Sarcoma Treatment Revenue Market Share by Type (2017-2028)
    Figure 74. Latin America Synovial Sarcoma Treatment Sales Market Share by Application (2017-2028)
    Figure 75. Latin America Synovial Sarcoma Treatment Revenue Market Share by Application (2017-2028)
    Figure 76. Latin America Synovial Sarcoma Treatment Sales Share by Country (2017-2028)
    Figure 77. Latin America Synovial Sarcoma Treatment Revenue Share by Country (2017-2028)
    Figure 78. Mexico Synovial Sarcoma Treatment Revenue (2017-2028) & (US$ Million)
    Figure 79. Brazil Synovial Sarcoma Treatment Revenue (2017-2028) & (US$ Million)
    Figure 80. Argentina Synovial Sarcoma Treatment Revenue (2017-2028) & (US$ Million)
    Figure 81. Middle East and Africa Synovial Sarcoma Treatment Sales Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Synovial Sarcoma Treatment Revenue Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Synovial Sarcoma Treatment Sales Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Synovial Sarcoma Treatment Revenue Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Synovial Sarcoma Treatment Sales Share by Country (2017-2028)
    Figure 86. Middle East and Africa Synovial Sarcoma Treatment Revenue Share by Country (2017-2028)
    Figure 87. Turkey Synovial Sarcoma Treatment Revenue (2017-2028) & (US$ Million)
    Figure 88. Saudi Arabia Synovial Sarcoma Treatment Revenue (2017-2028) & (US$ Million)
    Figure 89. UAE Synovial Sarcoma Treatment Revenue (2017-2028) & (US$ Million)
    Figure 90. Synovial Sarcoma Treatment Value Chain
    Figure 91. Synovial Sarcoma Treatment Production Process
    Figure 92. Channels of Distribution
    Figure 93. Distributors Profiles
    Figure 94. Bottom-up and Top-down Approaches for This Report
    Figure 95. Data Triangulation
    Figure 96. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Adaptimmune Therapeutics Plc
Advenchen Laboratories LLC
EpiZyme Inc
Immune Design Corp
Immunocore Ltd
Johnson & Johnson
Karyopharm Therapeutics Inc
Merck & Co Inc
Millennium Pharmaceuticals Inc
Novartis AG
Pfizer Inc
Takara Bio Inc
Frequently Asked Questions
Synovial Sarcoma Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Synovial Sarcoma Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Synovial Sarcoma Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Bronchitis Drug

Bronchitis Drug market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More